{"id":101298,"date":"2020-01-23T18:05:54","date_gmt":"2020-01-24T02:05:54","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/01\/stimulating-blood-vessel-growth-using-fgf1-may-hold-promise-for-pd-company-says"},"modified":"2020-01-23T18:05:54","modified_gmt":"2020-01-24T02:05:54","slug":"stimulating-blood-vessel-growth-using-fgf1-may-hold-promise-for-pd-company-says","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/01\/stimulating-blood-vessel-growth-using-fgf1-may-hold-promise-for-pd-company-says","title":{"rendered":"Stimulating Blood Vessel Growth Using FGF1 May Hold Promise for PD, Company Says"},"content":{"rendered":"<p style=\"padding-right: 20px\"><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/stimulating-blood-vessel-growth-using-fgf1-may-hold-promise-for-pd-company-says.jpg\"><\/a><\/p>\n<p>Stimulating the growth of blood vessels in the brain through the use of <a href=\"https:\/\/www.genecards.org\/cgi-bin\/carddisp.pl?gene=FGF1\">fibroblast growth factor 1<\/a> (FGF1) may hold promise as a strategy for treating <a href=\"https:\/\/parkinsonsnewstoday.com\/what-is-parkinsons-disease\/\">Parkinson\u2019s disease<\/a>, according to a white paper released by <a href=\"https:\/\/www.zhittyaregenerativemedicine.com\/home.html\">Zhittya Genesis Medicine<\/a> (ZGM). Clinical trials testing this theory are being planned.<\/p>\n<p>The white paper is titled \u201cParkinson\u2019s Disease: Therapeutic Angiogenesis as a Disease Modifying, Breakthrough Therapy?\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stimulating the growth of blood vessels in the brain through the use of fibroblast growth factor 1 (FGF1) may hold promise as a strategy for treating Parkinson\u2019s disease, according to a white paper released by Zhittya Genesis Medicine (ZGM). Clinical trials testing this theory are being planned. The white paper is titled \u201cParkinson\u2019s Disease: Therapeutic [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-101298","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/101298","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=101298"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/101298\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=101298"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=101298"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=101298"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}